Effective April 6th, 2021, CPL will perform all antibody testing for the Nucleocapsid antigen of SARS-CoV-2 (the causative agent of COVID-19) using the Roche Elecsys Anti-SARS-CoV-2 chemiluminescent immunoassay (unit code 7304). This is a sandwich immunoassay format designed to select for high-affinity total anti-COVID-19 antibody (IgG, IgA and IgM). The IgG-only COVID-19 Nucleocapsid antigen immunoassay will be discontinued (unit code 7301).

The Elecsys SARS-CoV-2 Nucleocapsid total antibody assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. As previously, this test should not be used to diagnose acute SARS-CoV-2 infection for which PCR testing is available. The assay can detect seropositivity in 60.2% of patients within the first week after PCR confirmation and sensitivity rises to 99.5% by day 14. Specificity is among the highest of immunoassays at 99.8%, and there is no cross-reactivity with ordinary endemic common-cold coronavirus species (HKU1, NL63, OC43, etc). For testing performed beyond 100 days, the Elecsys total-antibody assay remains persistently positive, whereas the IgG-only antibody assays show decreased sensitivity for prior COVID-19 infection.

UNIT CODE: 7301 – TO BE DISCONTINUED 7304
REPORTING TITLE: SARS–CoV–2 IgG Ab, N protein SARS–CoV–2 Total Ab, N protein
SPECIMEN REQUIREMENTS:

2 ML SERUM. ALLOW SST TO CLOT IN AN UPRIGHT POSITION FOR ATLEAST 30 MINUTES, THEN CENTRIFUGE SAMPLE WITHIN 2 HOURS OF COLLECTION. REFRIGERATE.
CLINICAL DATA IS REQUESTED FOR EPIDEMIOLOGY AND PUBLIC HEALTH PURPOSES.

SEE EXAMPLE REQUISTION/HISTORY SHEET LINK BELOW:

COVID-19 Requisition:  
http://www.cpllabs.com/COVID19_Req
COVID-19 History Form:  
http://www.cpllabs.com/COVID19_History_Form For more information, see URL: 
www.cpllabs.com/COVID-19-IgG-Serology7301

2 ML SERUM. ALLOW SST TO CLOT IN AN UPRIGHT POSITION FOR AT LEAST 30 MINUTES, THEN CENTRIFUGE SAMPLE WITHIN 2 HOURS OF COLLECTION.  REFRIGERATE.
CLINICAL DATA IS REQUESTED FOR EPIDEMIOLOGY AND PUBLIC HEALTH PURPOSES.

SEE EXAMPLE REQUISTION/HISTORY SHEET LINK BELOW:

COVID-19 Requisition:  
http://www.cpllabs.com/COVID19_Req
COVID-19 History Form:  
http://www.cpllabs.com/COVID19_History_Form
For more information, see URL:  
http://www.cpllabs.com/COVID-19-Total-Antibody
Para mas informacion en espanol, consulte la URL:  https://www.cpllabs.com/covid-19-total-antibody-spanish/

TRANSPORT TEMPERATURE: REFRIGERATED REFRIGERATED
MINIMUM SPECIMEN VOLUME: 1 ML SERUM OR EDTA PLASMA 1 ML SERUM
METHODOLOGY: CHEMILUMINESCENT MICROPARTICLE IMMUNOASSY (CMIA) ELECTROCHEMILUMINESCENCE IMMUNOASSAY (ECLIA)
REF. RANGE AND UNITS OF MEASURE:

< 1.4 = NEGATIVE

≥ 1.4 = POSITIVE

COI < 1.0 NEGATIVE

COI ≥ 1.0 POSITIVE

STABILITY:

2 DAYS ROOM TEMPERATURE

7 DAYS REFRIGERATED

1 MONTH FROZEN

3 DAYS ROOM TEMPERATURE

7 DAYS REFRIGERATED

28 DAYS FROZEN

CPT CODE: 86769 86769

 

Reference: 

Mohanraj D et al. Comparative assessment of SARS-CoV-2 serology in healthcare workers with Abbott Architect, Roche Elecsys and The Binding site ELISA immunoassays. medRxiv 2021.03.19.21253518; doi: https://doi.org/10.1101/2021.03.19.21253518